Cerebral Infarctions Completed Phase 4 Trials for Ozagrel (DB12017)

Also known as: Cerebral Infarct / Cerebral Infarction / Stroke NOS / Infarct cerebral

IndicationStatusPhase
DBCOND0047013 (Cerebral Infarctions)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00200356Edaravone-Sodium Ozagrel Comparative Post-Marketing Study on Acute Ischemic StrokeTreatment